Market closed

Champions Oncology/$CSBR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Champions Oncology

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Ticker

$CSBR
Trading on

Industry

Life Sciences Tools & Services

Employees

-

CSBR Metrics

BasicAdvanced
$103M
16.38
$0.46
0.20
-
$103M
0.2
$11.99
$3.75
44K
0.991
0.955
91.479
117.7
240.14%
14.64%
376.84%
16.375
1.74
18.77
20
-71.232
19.03%
-163.20%
7.78%
272.83%

What the Analysts think about CSBR

Analyst Ratings

Majority rating from 1 analysts.
Hold
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CSBR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Champions Oncology stock?

Champions Oncology (CSBR) has a market cap of $103M as of April 05, 2025.

What is the P/E ratio for Champions Oncology stock?

The price to earnings (P/E) ratio for Champions Oncology (CSBR) stock is 16.38 as of April 05, 2025.

Does Champions Oncology stock pay dividends?

No, Champions Oncology (CSBR) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Champions Oncology dividend payment date?

Champions Oncology (CSBR) stock does not pay dividends to its shareholders.

What is the beta indicator for Champions Oncology?

Champions Oncology (CSBR) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.